-
State Council: Take the price reduction as a breakthrough!
Time of Update: 2021-06-29
Medical Network News, June 18, June 17, the Chinese government website "Notice of the General Office of the State Council on Printing and Distributing Key Tasks for Deepening the Reform of the Medica
-
Deepening the reform of the medical and health system key tasks in 2021
Time of Update: 2021-06-29
Implement the healthy China strategy, promote the experience of Sanming’s medical reform, strengthen the linkage of the reform system, promote the balanced distribution of high-quality medical resources, coordinate the prevention and control of the epidemic and the construction of the public health system, and continue to focus on the transformation from disease treatment to people’s health.
-
High-end preparations are "increasing in value"! Qilu, Livzon, Beite...Lead the 6 golden tracks
Time of Update: 2021-06-29
The terminal sales of the hospital (referred to as China's public medical institutions) have exceeded 2 billion yuan, of which paclitaxel liposomes for injection are Luye Pharma’s exclusive products (including exclusive formulations, the same below) .
-
Analyzing the ten-year pattern of the global top 50 pharmaceutical industry: why Roche counterattacked Pfizer and why it has been falling frequently
Time of Update: 2021-06-29
The list includes the sales revenue, annual R&D investment and annual R&D investment of the top 50 global pharmaceutical companies in the prescription drug business in the past year.
-
The rise of TYK2 in the field of psoriasis in the JAK inhibitor war, who can break through, BMS, Pfizer, etc.
Time of Update: 2021-06-29
Approved JAK inhibitors for autoimmune diseasesThe first and second-generation JAK inhibitors that have been marketed mainly targeting JAK subtypes have obtained the largest indication population in autoimmune diseases-RA, and the current TYK2 specific inhibitors attack another autoimmune group.
-
Under the normalization of centralized procurement, chemical generic drug companies are developing diversified
Time of Update: 2021-06-29
Expand overseas channels and actively develop In recent years, assisted by the domestic generic drug consistency evaluation policy, a large number of generic drug companies have survived the fittest, and are also actively exploring export markets on the premise of improving their own quality.
-
Medical digitalization: The best experience for respondents is to make an online appointment, register and cancel the number
Time of Update: 2021-06-29
The best experience for interviewees is to make an online appointment and cancel the number Song Shuying, a post-90s graduate in Nanjing, now chooses to make an appointment online when going to the hospital .
-
All 3 specifications of Duloxetine Hydrochloride Enteric-coated Capsules of Enhua Pharmaceutical have been approved!
Time of Update: 2021-06-29
On the 18th, Enhua Pharmaceutical announced that the company has recently obtained the "Drug Registration Certificate" for the psychotropic drug duloxetine hydrochloride enteric-coated capsules 20mg, 30mg, and 60mg approved and issued by the National Medical Products Administration .
-
A batch of non-basic drugs is restricted
Time of Update: 2021-06-29
In December 2020, a tertiary grade A hospital in Guangdong Province required: Within the scope of the specialty, if the variety in use is non-National-based, it can be replaced by an application to change the national-based variety with the same generic name .
-
The new request to open a pharmacy is here
Time of Update: 2021-06-29
Under the conditions of ensuring the quality and safety of medicines throughout the delivery process and the effective implementation of pharmaceutical services by licensed pharmacists, further standardize drug Internet retail services .
-
The State Food and Drug Administration approves the listing of Hengrui Medicine's Hytrapopapaethanolamine Tablets
Time of Update: 2021-06-29
According to relevant statistics, there are currently 5 approved TPO-R drugs in the world, including Lutrobopal, Eltrobopal, Romigrastim, Alvatrobopal, and Thrombopoietin; currently, approved domestically Among them are 3SBio's recombinant human thrombopoietin, Novartis's Eltropopa ethanolamine tablets, and Fosun Pharma's introduction of AkaRx, Inc.
-
Zhongsheng Pharmaceutical's FGFR4 inhibitor compound patent was authorized by the U.S. Patent Office
Time of Update: 2021-06-29
This patent is a compound patent for the innovative drug ZSP1241 project deployed by Zhongsheng Pharmaceutical in the field of anti-tumor, and belongs to the core patent of the project .
-
New trends in drug procurement: Dolutegravir sodium tablets and other drugs resume procurement qualifications
Time of Update: 2021-06-29
The notice stated that three drugs including dolutegravir sodium tablets were indeed purchased on Sunshine Platform during the statistical period (April 1, 2020 to March 31, 2021).
After commercial research, it is now agreed to resume dolutegravir sodium tablets.
-
BeiGene ``Zebutinib Capsules'' New Indication Approved
Time of Update: 2021-06-28
The NMPA conditional approval of Baiyueze for the treatment of WM patients who have received at least one treatment in the past is based on the safety and efficacy results of a key single-arm phase II clinical trial (NCT03332173) .
-
Double resistance arena!
Time of Update: 2021-06-28
From the concept of dual antibodies, only four bispecific antibodies have been approved globally in the past 60 years, and the first marketed drug has been suspended due to commercialization.
With the development of dual-antibody drug research, a new generation of anti-angiogenesis treatment methods are emerging .
-
WHO releases the latest data on the cumulative number of confirmed cases of new crowns worldwide
Time of Update: 2021-06-28
WHO: The global cumulative number of confirmed cases of new crown reached 176,303,596 WHO: The global cumulative number of confirmed cases of new crown reached 176,303,596 WHO: The
-
Japanese research found that the sequelae of new coronary pneumonia can last for more than half a year
Time of Update: 2021-06-28
Regarding whether patients with new coronary pneumonia have abnormal smell and taste after six months of diagnosis, a research team led by Professor Sanlun Gaoxi of Kanazawa Medical University in Japan surveyed 251 patients under 60 and found that 61% of the respondents were "abnormal in the sense of smell, taste" .
-
Is there a way to prevent Marek's disease?
Time of Update: 2021-06-28
Vaccines Vaccines Vaccines Experimental materials and methodsExperimental materials and methods The author used a two-step Red-mediated recombination procedure to construct meq and/or vIL8 single and double deletion viruses, respectively, using immunofluorescence and immunohistochemistry techniques to determine in vitro growth viability, MDV genome copy number, and reactivate the virus in chickens.
-
42 drugs delisted: Huanglian Shangqing Pills, Huoxiang Zhengqi Pills...
Time of Update: 2021-06-28
On December 9th of the same year, the State Food and Drug Administration announced that it decided to cancel compound acetylsalicylic acid tablets, indomethacin enteric-coated tablets, paracetamol tablets, cefradine capsules, pain relief tablets, compound salvia tablets, Huoxiang Zhengqi 115 pharmaceutical registration certificates including water .
-
The second shot of the new crown vaccine is more painful than the first shot?
Time of Update: 2021-06-28
Expert: There is no scientific basis, it is an individual difference Is the second shot of the new crown vaccine more painful than the first shot?
Expert: There is no scientific basis, it is an individual difference Is the second shot of the new crown vaccine more painful than the first shot?
